Related Experiment Video
Updated: Jun 4, 2025

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Disruption of deoxyribonucleotide triphosphate biosynthesis leads to RAS proto-oncogene activation and perturbation
Rodolphe Suspène1, Kyle A Raymond2, Pablo Guardado-Calvo3
1Virus and Cellular Stress Unit, Department of Virology, Université Paris Cité, Institut Pasteur, Paris, France.
Abstract:
Perturbation of the deoxyribonucleotide triphosphate (dNTP) pool is recognized for contributing to the mutagenic processes involved in oncogenesis. The RAS gene family encodes well-characterized oncoproteins whose structure and function are among the most frequently altered in several cancers. In this work, we show that fluctuation of the dNTP pool induces CG → TA mutations across the whole genome, including RAS gene at codons for glycine 12 and 13, known hotspots in cancers. Cell culture addition of the ribonucleotide reductase inhibitor thymidine increases the mutation frequency in nuclear DNA and leads to disruption of mitochondrial metabolism. Interestingly, this effect is counteracted by the addition of deoxycytidine. Finally, screening for the loss of hydrogen bonds detecting CG → TA transition in RAS gene of 135 patients with colorectal cancer confirmed the clinical relevance of this process. All together, these data demonstrate that fluctuation of intracellular dNTP pool alters the nuclear DNA and mitochondrial metabolism.
Insights
Altering deoxyribonucleotide triphosphate (dNTP) pools causes specific DNA mutations in cancer genes like RAS. This impacts nuclear DNA and mitochondrial metabolism, with clinical relevance in colorectal cancer.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Perturbation of deoxyribonucleotide triphosphate (dNTP) pools is linked to oncogenesis.
- The RAS gene family is frequently altered in various cancers.
Purpose of the Study:
- To investigate how dNTP pool fluctuations induce specific mutations, particularly CG → TA transitions.
- To explore the impact of these mutations on RAS genes and mitochondrial metabolism.
- To confirm the clinical relevance of these findings in colorectal cancer patients.
Main Methods:
- Utilized cell culture models to study dNTP pool alterations.
- Administered thymidine (ribonucleotide reductase inhibitor) and deoxycytidine.
- Analyzed mutation frequencies in nuclear DNA and mitochondrial metabolism.
- Screened RAS genes from colorectal cancer patients for CG → TA transitions.
Main Results:
- dNTP pool fluctuations induce CG → TA mutations genome-wide, including RAS hotspots.
- Thymidine treatment increased mutation frequency and disrupted mitochondrial metabolism.
- Deoxycytidine addition counteracted these effects.
- Clinical screening confirmed CG → TA transitions in RAS genes of colorectal cancer patients.
Conclusions:
- Intracellular dNTP pool fluctuations drive specific DNA mutations and alter mitochondrial metabolism.
- These findings highlight a novel mechanism in cancer development and progression.
- Targeting dNTP pools may offer new therapeutic strategies for cancer treatment.
Related Concept Videos
The Ras Gene
Ras is a...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
MAPK Signaling Cascades
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Biosynthesis of Nucleic Acids

